CXCR4 and cancer: On the other hand, CXCR4 showed a strong association with poor survival (HR = 1.38, 95% CI: 1.27–1.49), which is consistent with numerous studies, including [83, 84], that have implicated CXCR4 in metastasis and poor prognosis across various cancers.